New data underscore the importance of genomic profiling for African-American women with breast cancer, whose unique tumor biology can sometimes lead to poorer prognoses than those for Caucasian women.
Read More
A recent study shows that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies.
Read More
The study’s objective was to evaluate the ability of the Prolaris test and the Prolaris test combined with clinical information to predict a patient’s 10-year risk of progression to metastatic disease.
Read More
Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.
Read More
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read More